Related Experiment Video

Updated: Jun 11, 2026

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates
06:10

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates

Published on: May 9, 2025

Development of non-viral vector for cancer gene therapy

Yoshiyuki Hattori1

  • 1Institute of Medicinal Chemistry, Hoshi University, 2-4-41 Ebara, Shinagawa-ku, tokyo, Japan. yhattori@hosshi.ac.jp

Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan
|July 8, 2010
PubMed

Insights

New cationic nanoparticles effectively deliver gene therapy agents like plasmid DNA and small interfering RNA to tumors. Folate-linked versions further enhance targeted delivery, significantly inhibiting tumor growth in preclinical models.

Area of Science:

  • Biotechnology
  • Nanomedicine
  • Cancer Research

Background:

  • Non-viral vectors, particularly cationic liposomes and nanoparticles, are crucial for cancer gene therapy.
  • Efficient delivery of plasmid DNA (pDNA) or small interfering RNA (siRNA) to tumor cells with low toxicity is essential for effective gene therapy.

Purpose of the Study:

  • To develop and evaluate novel cationic nanoparticles (NP) for efficient pDNA and siRNA delivery in cancer gene therapy.
  • To create folate-linked nanoparticles (NP-F) for targeted delivery to folate receptor-overexpressing tumors.
  • To assess the therapeutic efficacy of NP-F in inhibiting tumor growth.

Main Methods:

  • Synthesized new cationic nanoparticles (NP) using cholesteryl-3beta-carboxyamidoethylene-N-hydroxyethylamine (OH-Chol) and Tween 80.
  • Evaluated pDNA and siRNA transfection efficiencies of NP in human prostate tumor PC-3 xenografts.
  • Developed folate-linked nanoparticles (NP-F) by conjugating folate to NP components.
  • Assessed tumor growth inhibition in FR-positive human nasopharyngeal tumor KB xenografts using NP-F complexes.

Main Results:

  • Direct injection of NP demonstrated effective pDNA and siRNA transfection in PC-3 xenografts.
  • NP-F complexes carrying a therapeutic gene significantly inhibited tumor growth in KB xenografts.
  • Folate receptor-mediated targeting enhanced the therapeutic effect of the nanoparticles.

Conclusions:

  • Cationic cholesterol-based nanoparticles show promise as non-viral vectors for pDNA and siRNA delivery.
  • These nanoparticles are suitable for local tumor treatment strategies.
  • Folate conjugation offers a viable approach for targeted cancer gene therapy.

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.